Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Immune Deficiency: early-phase trial registry
4 of 7 indexed Immune Deficiency trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 4 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Immune Deficiency: 7 US clinical trials tracked, 4 recruiting.
Immune Deficiency is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Columbia University, running 2 of these trials.
Enrollment posture brief
Registry condition immune-deficiency
OPEN 4 | RECR 57% | LATE 0 | EARLY 3 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adverse Childhood Experiences (57% recruiting · 14 trials)
Immune Deficiency lists 4 open slots (57% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Immune Deficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Immune Deficiency is recruiting above its size-band peers.
4 of 7 indexed trials (57.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Immune Deficiency research.
Columbia University accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Immune Deficiency trials plan to enrol fewer than 100 people.
Median target enrolment is 18 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.
-
Immune Deficiency splits between interventional and observational designs.
4 interventional and 3 observational studies make up this index (57.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Allergy and Immunology Natural History Study
Columbia University
NCT05584488
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Washington University School of Medicine
NCT06689800
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Columbia University
NCT06926894
X-linked Moesin Associated Immunodeficiency
Institut National de la Santé Et de la Recherche Médicale, France
NCT06278337
Immunoglobulin G Therapy Dose Optimization
Rutgers, The State University of New Jersey
NCT04818177
Adoptive Transfer of Haploidentical NK Cells and N-803
University of Minnesota
NCT03899480
Personalized Immunotherapeutic for Antibiotic-resistant Infection
Brigham and Women's Hospital
NCT02508584
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Immune Deficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Immune Deficiency trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Immune Deficiency page
7 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Immune Deficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Columbia University sponsors the most Immune Deficiency trials on record, review their full trial history before evaluating a specific study. See Columbia University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Immune Deficiency condition card totals 7 registered trials; most-linked intervention anti-mycoplasma hominis antibodies; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.